Meissner: Nothing holding back single-use as it expands filtration ops

By Dan Stanton contact

- Last updated on GMT

Meissner: Nothing holding back single-use as it expands filtration ops

Related tags: Disposable

Nothing is holding back the adoption of single-use filtration products says Meissner, which has expanded its facility in California. 

The new 176,000sq ft site will support future growth for Meissner Filtration Products, whose range of products include a number of microfiltration systems used for downstream processes in biomanufacturing.

“Meissner needed to expand its operational footprint to include a facility that would accommodate growth both in terms of production capacity as well as support services,”​ the firm’s Director of Operations, Max Blomberg, told Biopharma-Reporter.com.

He added the site in Camarillo, California “facilitates both of these goals via 40,000 sq ft of cleanroom manufacturing space, as well as state of the art laboratory facilities with support functions including testing, advanced analytics, validation services, and product development.”

The expansion is part of Meissner’s vertical integration strategy which Blomberg told us has enabled the firm “to design products to be as pure as possible, at a time when the benefits of such efforts were largely theoretical, but now have demonstrated tangible benefits.”

Single-Use Adoption

Meissner offers a number of disposable biocontainers, rigid outer containers and fluid path assemblies under its One-Touch portfolio, in order to support the adoption of single-use In bioprocessing.

“Any time a new technology is introduced, adoption is best undertaken to minimize risk and maximize reward,”​ Blomberg said. “We do not think anything is holding back single-use filtration products or systems at large.”

However, he continued, each application should undergo its own risk analysis to ensure the desired benefits are achieved and “in many cases, the optimum solutions remain hybrid systems where traditional multi-use systems are integrated with single-use technology to maximize the benefits of both.”

Related news

Show more

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

CadenceILC_610x343

Inline concentration improves process economics

Pall Biotech | 15-Jun-2018 | Case Study

Would you like to enhance your downstream process, increase production capacity and reduce costs? This case study application note demonstrates how implementing...

Related suppliers

Follow us

Products

View more

Webinars